Company Filing History:
Years Active: 2011-2018
Title: Hui-Ya Ho: Innovator in Diabetes and Hyperlipidemia Treatment
Introduction
Hui-Ya Ho is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of type 2 diabetes and hyperlipidemia. With a total of 5 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of his latest patents is titled "Method and composition for treatment or prevention of type 2 diabetes and hyperlipidemia." This invention provides a method for treating or preventing these conditions by administering a therapeutically effective amount of a compound of formula I. The pharmaceutical composition includes this compound along with a pharmaceutically acceptable carrier. The compound exerts antidiabetic and antihyperlipidemic effects by down-regulating specific enzymes and promoting the expression of GLUT4, leading to reduced visceral fat and lower blood levels of triglycerides, glucose, and insulin. Another notable patent involves a pharmaceutical composition useful for hepatoprotection, which comprises an effective amount of kinsenoside or its pharmaceutically acceptable salt or ester.
Career Highlights
Hui-Ya Ho has worked with notable institutions, including China Medical University and Chun-Ching Shih. His research and innovations have garnered attention in the pharmaceutical community, showcasing his dedication to improving health outcomes.
Collaborations
Hui-Ya Ho has collaborated with several professionals in his field, including Jin-Bin Wu and Wen-Chuan Lin. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Hui-Ya Ho is a distinguished inventor whose work in diabetes and hyperlipidemia treatment is paving the way for innovative pharmaceutical solutions. His contributions are vital in addressing these prevalent health issues.